688363.SH
Bloomage Biotechnology Corp. Ltd.
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 34.23
−0.58%Year over year
Reported trailing growth
- Revenue
- -22.4%
- EBITDA
- —
- EBIT
- +446.3%
- EPS
- +681.7%
- Free cash flow
- +648.0%
- Operating cash flow
- +54.2%
Forward estimates
Based on analyst estimates
- Revenue
- -73.2%
- EBITDA
- -67.7%
- EPS
- -63.4%
Three-year CAGR
- Revenue
- -12.9%
- EBITDA
- -19.9%
- EBIT
- -33.6%
- Net income
- -33.0%
- EPS
- -32.9%
- Free cash flow
- +292.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026